Alphatec Spine Announces Restructured and Expanded Credit Facility

Alphatec Spine Announces Restructured and Expanded Credit Facility

CARLSBAD, Calif., Sept. 16, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc.
(Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device
company that provides physician-inspired solutions for patients with spinal
disorders, announced today that it has amended its existing credit facility
with MidCap Financial. The revised credit facility increases Alphatec Spine,
Inc.'s current financing capability by providing access to up to an aggregate
maximum amount of $73.0 million. The revised facility consists of a $40.0
million revolving line of credit supported by a $33.0 million term loan, which
is due July 2016. The amended credit facility will be used to support the
Company's general operational purposes and working capital needs.

"We have worked hard to build a strong working relationship with MidCap
Financial and appreciate their continued support," said Les Cross, Alphatec
Spine's Chairman and Chief Executive Officer. "The revised credit facility
provides us with additional flexibility and liquidity. With this facility in
place, we should be well positioned to continue to fund our ongoing
operational and commercial activities as well as providing additional capacity
for future accretive transactions."

"We have enjoyed partnering with Alphatec Spine since the origination of the
initial credit facility that we established in June 2012," said Matt Pappano,
Vice President-Portfolio Manager at MidCap Financial. "Over the last fifteen
months we have been very pleased to see the company's continued growth and
positive performance of the business. We're delighted to further assist
Alphatec Spine in continuing to deliver their business objectives by now
providing the company with additional flexible capital."

Further information regarding the Company's recent strategic debt
restructuring transaction with MidCap Financial is set forth in a Current
Report on Form 8-K that was filed with the U.S. Securities and Exchange
Commission (SEC) on September 6, 2013 and is available on both the SEC's
website at and the Company's website at

About Alphatec Spine

Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec Holdings, Inc., is
a medical device company that designs, develops, manufactures and markets
physician-inspired products and solutions for the treatment of spinal
disorders associated with trauma, congenital deformities, disease and
degeneration. The Company's mission is to combine innovative surgical
solutions with world-class customer service to improve outcomes and patient
quality of life. The Company and its affiliates market products in the U.S.
and in over 50 countries internationally via a direct sales force and
independent distributors.

Additional information can be found at

About MidCap Financial, LLC

MidCap Financial is a commercial finance company focused on middle market
lending in the broad national healthcare industry. MidCap specializes in $5
million to $200 million loans. The company is headquartered in Bethesda, MD,
with offices in Chicago and Los Angeles, and focuses in four areas:

-Asset-Based working capital loans to healthcare providers collateralized by
third-party accounts receivable and other assets;
-Leveraged loans to healthcare companies backed by private equity sponsors;
-Life Sciences loans to VC-backed and public pharmaceutical, biotech, and
medical device companies;
-Real Estate loans to skilled nursing facilities, senior housing properties,
and medical office buildings

Additional information about MidCap Financial can be found at

Forward Looking Statements

This press release may contain "forward-looking statements" within the meaning
of the Private Securities Litigation Reform Act of 1995 that involve risks and
uncertainty. Such statements are based on management's current expectations
and are subject to a number of risks and uncertainties that could cause actual
results to differ materially from those described in the forward looking
statements. Alphatec Spine cautions investors that there can be no assurance
that actual results or business conditions will not differ materially from
those projected or suggested in such forward-looking statements as a result of
various factors. Forward looking statements include references to Alphatec
Spine's 2013 growth, revenue, and adjusted EBITDA projections; the Company's
ability to take advantage of the maximum amount of its new credit facility,
and Alphatec Spine's ability to continue to fund its ongoing operational and
commercial activities and future accretive transactions. Please refer to the
risks detailed from time to time in Alphatec Spine's SEC reports, including
its Annual Report Form 10-K for the year ended December 31, 2012, filed on
March 4, 2013 with the Securities and Exchange Commission, as well as other
filings on Form 10-Q and periodic filings on Form 8-K. Alphatec Spine
disclaims any intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events, or
otherwise, unless required by law.

CONTACT: Investor/Media Contact:
         Christine Zedelmayer
         Investor Relations
         Alphatec Spine, Inc.
         (760) 494-6610

Alphatec Spine
Press spacebar to pause and continue. Press esc to stop.